Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.
BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...
Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
Covidien has announced it has received FDA clearance to market the Covidien Nellcor Bedside SpO2 Patient Monitoring System, according to a news release. The Nellcor Bedside SpO2 system includes the ...
DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...
BOULDER, Colo.--(BUSINESS WIRE)--Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD). 1 It is a condition that is often easily detectable and ...
There’s a new wearable tech metric in town – and it’s all about blood oxygen. It might sound complicated and a little pointless, but pulse ox can reveal conditions like sleep apnea – and help athletes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results